141 related articles for article (PubMed ID: 33709489)
1. Analysis of malignant melanoma risk and outcomes in solid organ transplant recipients: Assessment of transplant candidacy and the potential role of checkpoint inhibitors.
Zwald F; Carvajal RD; Walker J; Sawinski D; Al-Adra D
Clin Transplant; 2021 May; 35(5):e14264. PubMed ID: 33709489
[TBL] [Abstract][Full Text] [Related]
2. Melanoma in Solid Organ Transplant Recipients.
González-Cruz C; Ferrándiz-Pulido C; García-Patos Briones V
Actas Dermosifiliogr (Engl Ed); 2021 Mar; 112(3):216-224. PubMed ID: 33197437
[TBL] [Abstract][Full Text] [Related]
3. Malignant melanoma in organ transplant recipients: incidence, outcomes, and management strategies: a review of literature.
Džambová M; Sečníková Z; Jiráková A; Jůzlová K; Viklický O; Hošková L; Göpfertovà D; Hercogová J
Dermatol Ther; 2016; 29(1):64-8. PubMed ID: 26460720
[TBL] [Abstract][Full Text] [Related]
4. Melanoma Outcomes in Transplant Recipients With Pretransplant Melanoma.
Arron ST; Raymond AK; Yanik EL; Castenson D; McCulloch CE; Clarke CA; Paddock LE; Niu X; Engels EA
Dermatol Surg; 2016 Feb; 42(2):157-66. PubMed ID: 26818209
[TBL] [Abstract][Full Text] [Related]
5. Recommendations for Solid Organ Transplantation for Transplant Candidates With a Pretransplant Diagnosis of Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma and Melanoma: A Consensus Opinion From the International Transplant Skin Cancer Collaborative (ITSCC).
Zwald F; Leitenberger J; Zeitouni N; Soon S; Brewer J; Arron S; Bordeaux J; Chung C; Abdelmalek M; Billingsley E; Vidimos A; Stasko T
Am J Transplant; 2016 Feb; 16(2):407-13. PubMed ID: 26820755
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous melanoma in solid organ transplant patients.
Russo I; Piaserico S; Belloni-Fortina A; Alaibac M
G Ital Dermatol Venereol; 2014 Aug; 149(4):389-94. PubMed ID: 25068225
[TBL] [Abstract][Full Text] [Related]
7. Melanoma in a cohort of organ transplant recipients: Experience from a dedicated transplant dermatology clinic in Victoria, Australia.
Maor D; Vajdic CM; Cumming S; Fahey V; Bala HR; Snaidr V; Brennand S; Goh MSY; Chong AH
J Am Acad Dermatol; 2020 Sep; 83(3):773-779. PubMed ID: 31706934
[TBL] [Abstract][Full Text] [Related]
8. Melanoma incidence, stage, and survival after solid organ transplant: A population-based cohort study in Ontario, Canada.
Park CK; Dahlke EJ; Fung K; Kitchen J; Austin PC; Rochon PA; Chan AW
J Am Acad Dermatol; 2020 Sep; 83(3):754-761. PubMed ID: 32111554
[TBL] [Abstract][Full Text] [Related]
9. Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement.
Al-Adra DP; Hammel L; Roberts J; Woodle ES; Levine D; Mandelbrot D; Verna E; Locke J; D'Cunha J; Farr M; Sawinski D; Agarwal PK; Plichta J; Pruthi S; Farr D; Carvajal R; Walker J; Zwald F; Habermann T; Gertz M; Bierman P; Dizon DS; Langstraat C; Al-Qaoud T; Eggener S; Richgels JP; Chang GJ; Geltzeiler C; Sapisochin G; Ricciardi R; Krupnick AS; Kennedy C; Mohindra N; Foley DP; Watt KD
Am J Transplant; 2021 Feb; 21(2):475-483. PubMed ID: 32976703
[TBL] [Abstract][Full Text] [Related]
10. Systemic strategies for chemoprevention of skin cancers in transplant recipients.
Kovach BT; Sams HH; Stasko T
Clin Transplant; 2005 Dec; 19(6):726-34. PubMed ID: 16313317
[TBL] [Abstract][Full Text] [Related]
11. Immune checkpoint inhibitors in the management of malignancies in transplant recipients.
Regalla DKR; Williams GR; Paluri RK
Postgrad Med J; 2018 Dec; 94(1118):704-708. PubMed ID: 30425139
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous Malignancies in Pediatric Solid Organ Transplant Recipients.
Fogel AL; Miyar M; Teng JM
Pediatr Dermatol; 2016 Nov; 33(6):585-593. PubMed ID: 27470071
[TBL] [Abstract][Full Text] [Related]
13. Association of HLA Antigen Mismatch With Risk of Developing Skin Cancer After Solid-Organ Transplant.
Gao Y; Twigg AR; Hirose R; Roll GR; Nowacki AS; Maytin EV; Vidimos AT; Rajalingam R; Arron ST
JAMA Dermatol; 2019 Mar; 155(3):307-314. PubMed ID: 30673077
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of melanoma in recipients of solid organ transplant.
Dapprich DC; Weenig RH; Rohlinger AL; Weaver AL; Quan KK; Keeling JH; Walsh JS; Otley CC; Christenson LJ
J Am Acad Dermatol; 2008 Sep; 59(3):405-17. PubMed ID: 18556089
[TBL] [Abstract][Full Text] [Related]
15. Organ transplantation and outcomes in patients with a past history of melanoma: A systematic review and meta-analysis.
Williams GJ; Webster AC; Thompson JF
Clin Transplant; 2021 Jun; 35(6):e14287. PubMed ID: 33720403
[TBL] [Abstract][Full Text] [Related]
16. Non-melanoma skin cancer is reduced after switch of immunosuppression to mTOR-inhibitors in organ transplant recipients.
Alter M; Satzger I; Schrem H; Kaltenborn A; Kapp A; Gutzmer R
J Dtsch Dermatol Ges; 2014 Jun; 12(6):480-8. PubMed ID: 24813579
[TBL] [Abstract][Full Text] [Related]
17. Skin Cancer Following Solid Organ Transplantation: A Review of Risk Factors and Models of Care.
Howard MD; Su JC; Chong AH
Am J Clin Dermatol; 2018 Aug; 19(4):585-597. PubMed ID: 29691768
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of malignant melanoma in kidney transplant recipients
.
Di Bartolomeo S; Rolak S; Joachim E; Xu YG; Astor BC; Parajuli S
Clin Nephrol; 2019 Dec; 92(6):293-301. PubMed ID: 31549628
[TBL] [Abstract][Full Text] [Related]
19. Donor-Transmitted Melanoma: Is It Still Bothering Us?
Abdullayeva L
Curr Treat Options Oncol; 2020 Apr; 21(5):38. PubMed ID: 32328846
[TBL] [Abstract][Full Text] [Related]
20. Malignancy after Solid Organ Transplantation: Comprehensive Imaging Review.
Katabathina VS; Menias CO; Tammisetti VS; Lubner MG; Kielar A; Shaaban A; Mansour J; Surabhi VR; Hara AK
Radiographics; 2016; 36(5):1390-407. PubMed ID: 27618321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
